Eledon Pharmaceuticals, Inc.·4

Dec 21, 4:05 PM ET

Gros David-Alexandre C 4

4 · Eledon Pharmaceuticals, Inc. · Filed Dec 21, 2021

Insider Transaction Report

Form 4
Period: 2021-12-20
Gros David-Alexandre C
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2021-12-20$4.48/sh+2,000$8,9609,000 total
Footnotes (1)
  • [F1]These shares were purchased in an open market transaction in accordance with the Issuer's trading policies.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION